Press — Updates & Announcements — Omega Funds

LinkedIn Email

888 Boylston Street, Suite 1111
Boston, MA 02199

All Rights Reserved. Omega Fund Management, LLC 2021

Site by Impression Studio

Updates &
Announcements

View all press

May 4, 2021

Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021

Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021

April 28, 2021

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

April 26, 2021

Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast

Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast

February 12, 2021

2021: The Rise of the Variants – TimmermanReport.com

2021: The Rise of the Variants – TimmermanReport.com

January 14, 2021

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

January 7, 2021

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

January 7, 2021

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies

January 7, 2021

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease

January 6, 2021

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

January 5, 2021

Ikena Oncology Closes $120 Million Series B Financing Led by Omega Funds

Ikena Oncology Closes $120 Million Series B Financing Led by Omega Funds

4 May 2021

Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021

BIO Deutschland

Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021

28 Apr 2021

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

Morphic Therapeutic

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

26 Apr 2021

Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast

RBC Capital Markets

Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast

12 Feb 2021

2021: The Rise of the Variants – TimmermanReport.com

The Timmerman Report

2021: The Rise of the Variants – TimmermanReport.com

14 Jan 2021

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

Wall Street Journal

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

7 Jan 2021

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

Scorpion Therapeutics

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

7 Jan 2021

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies

Lexeo Therapeutics

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies

7 Jan 2021

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease

Endeavor BioMedicines

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease